USPTO serial 88872882
INNOCOLL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 20, 2021
- Examiner
- MAYES, LAURIE ANN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with INNOCOLL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*
Plus Government fees of $975
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Innocoll Pharmaceuticals Limited
Althone, Co. Roscommon, IE
Innocoll Pharmaceuticals Limited
Althone, Co. Roscommon, IE
Innocoll Pharmaceuticals Limited
Althone, Co. Roscommon, IE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Camille M. Miller
Camille M. Miller COZEN O'CONNOR1650 MARKET STREETSUITE 2800PHILADELPHIA, PA 19103Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical, veterinary and sanitary preparations for the treatment of wounds, burns and for the treatment of scars after surgery; wound dressings, foils being wound dressings, medicated compresses, wadding for dressings, foaming pharmaceutical preparations for wounds, semi-liquid matrice in the nature of antiseptic liquid bandages, barriers being medical dressings, bandages for skin wounds, sponges impregnated with antiseptics, and all for medical use in or on the human or non-human animal body; wound dressings, foils being wound dressings, medicated compresses, wadding for dressings, foaming pharmaceutical preparations for wounds, semi-liquid matrices being wound dressings, barriers being medical dressings, bandages for skin wounds, sponges impregnated with antiseptics all for medical use and made from or incorporating collagen; collagen wound dressings, foils being wound dressings, medicated compresses, wadding for dressings, foaming pharmaceutical preparations for wounds, semi-liquid matrices being medical dressings, barriers being medical dressings, surgical bandages, films being surgical dressings, membranes being surgical dressings for medical use as a temporary dermoplasty; surgical implants made from living collagen tissue for use in skin repair and skin improvement; surgical and medical implant comprised of living collagen tissue for medical purposes; surgical implants comprising living collagen tissue for wound management and pain relief | ACTIVE | — |
| 010 | Medical non-living implants comprised of a non-living collagen and extracellular matrix composition; semi-liquid matrices in the nature of implantable scaffolds comprising living collagen tissue for maintaining tissue contour; implants comprising natural, non-living materials for use in skin repair and skin improvement; non-living surgical and medical implants composed of collagen; collagen constructs for medical, surgical or veterinary purposes in the nature of implantable scaffolds comprising artificial materials for maintaining tissue contour; natural collagen based surgical, non-living implants for management of post-operative pain; natural collagen based surgical, non-living implants for wound management | ACTIVE | — |
| 042 | Medical and scientific research services in the field of collagen based drug delivery systems; Medical and scientific research services for medical, veterinary and pharmaceutical purposes; scientific research in the fields of chemistry and biochemistry; consultancy services relating to scientific research into the development of medical and surgical products; contract scientific research services, scientific research and development of medical and surgical products for others; laboratory scientific research services relating to medical and surgical products; industrial analysis services, namely, collagen based chemical analysis services for medical, veterinary and pharmaceutical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Innocoll Pharmaceuticals Limited
- Other trademarks owned by Innocoll Pharmaceuticals Limited
- Other trademarks owned by Innocoll Pharmaceuticals Limited
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named INNOCOLL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 20, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Nov 8, 2023 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Apr 20, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 2, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 2, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 13, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 29, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 11, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 11, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 11, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 8, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 8, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 8, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 23, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 23, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 19, 2020 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| May 26, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| May 26, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| May 26, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 19, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 19, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 18, 2020 | ALIE | ASSIGNED TO LIE | — |
| May 12, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 12, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 12, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 12, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 12, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 23, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 18, 2020 | NWAP | NEW APPLICATION ENTERED | — |